A Risk Score Based on Immune- and Oxidative Stress-Related LncRNAs Predicts Prognosis in Lung Adenocarcinoma: Insights from in vitro Experiments and Large-Scale Transcriptome Analysis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398(10299):535–554. doi:10.1016/S0140-6736(21)00312-3
   PubMed Web of Science ®Google Scholar
• Wu F, Wang L, Zhou C. Lung cancer in China: current and prospect. Curr Opin Oncol. 2021;33(1):40–46. doi:10.1097/CCO.0000000000000703
   PubMed Web of Science ®Google Scholar
• Brody H. Lung cancer. Nature. 2020;587(7834):S7. doi:10.1038/d41586-020-03152-0
   PubMed Web of Science ®Google Scholar
• Singh T, Fatehi Hassanabad M, Fatehi Hassanabad A. Non-small cell lung cancer: emerging molecular targeted and immunotherapeutic agents. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188636. doi:10.1016/j.bbcan.2021.188636
   PubMed Web of Science ®Google Scholar
• Gupta RK, Patel AK, Shah N, et al. Oxidative stress and antioxidants in disease and cancer: a review. Asian Pac J Cancer Prev. 2014;15(11):4405–4409. doi:10.7314/apjcp.2014.15.11.4405
   PubMedGoogle Scholar
• Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931–947. doi:10.1038/nrd4002
   PubMed Web of Science ®Google Scholar
• Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12(1):376–390. doi:10.1016/j.arr.2012.10.004
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49(11):1603–1616. doi:10.1016/j.freeradbiomed.2010.09.006
   PubMed Web of Science ®Google Scholar
• Zhao F, Li Y, Dong Z, et al. Identification of a risk signature based on lactic acid metabolism-related LncRNAs in patients with esophageal squamous cell carcinoma. Front Cell Dev Biol. 2022;10:845293. doi:10.3389/fcell.2022.845293
   Web of Science ®Google Scholar
• Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118. doi:10.1038/s41580-020-00315-9
   PubMed Web of Science ®Google Scholar
• Zhang L, Peng D, Sood AK, Dang CV, Zhong X. Shedding light on the dark cancer genomes: long noncoding RNAs as novel biomarkers and potential therapeutic targets for cancer. Mol Cancer Ther. 2018;17(9):1816–1823. doi:10.1158/1535-7163.MCT-18-0124
   PubMed Web of Science ®Google Scholar
• Atianand MK, Caffrey DR, Fitzgerald KA. Immunobiology of long noncoding RNAs. Annu Rev Immunol. 2017;35:177–198. doi:10.1146/annurev-immunol-041015-055459
   PubMed Web of Science ®Google Scholar
• Kim C, Kang D, Lee EK, Lee JS. Long noncoding RNAs and RNA-binding proteins in oxidative stress, cellular senescence, and age-related diseases. Oxid Med Cell Longev. 2017;2017:2062384. doi:10.1155/2017/2062384
   Web of Science ®Google Scholar
• Fuschi P, Carrara M, Voellenkle C, et al. Central role of the p53 pathway in the noncoding-RNA response to oxidative stress. Aging. 2017;9(12):2559–2586. doi:10.18632/aging.101341
   PubMedGoogle Scholar
• Carninci P, Kasukawa T, Katayama S, et al. The transcriptional landscape of the mammalian genome. Science. 2005;309(5740):1559–1563. doi:10.1126/science.1112014
   PubMed Web of Science ®Google Scholar
• Ravasi T, Suzuki H, Pang KC, et al. Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res. 2006;16(1):11–19. doi:10.1101/gr.4200206
   PubMed Web of Science ®Google Scholar
• Ma S, Wang Y, Li W, et al. Integrated analysis identities Rho GTPases related molecular map in patients with gastric carcinoma. Sci Rep. 2023;13(1):21443. doi:10.1038/s41598-023-48294-z
   Google Scholar
• Ye F, Hu Y, Gao J, et al. Radiogenomics map reveals the landscape of m6A methylation modification pattern in bladder cancer. Front Immunol. 2021;12:722642. doi:10.3389/fimmu.2021.722642
   Web of Science ®Google Scholar
• Sturm G, Finotello F, Petitprez F, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019;35(14):i436–i445. doi:10.1093/bioinformatics/btz363
   PubMed Web of Science ®Google Scholar
• Jia Q, Wu W, Wang Y, et al. Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 2018;9(1):5361. doi:10.1038/s41467-018-07767-w
   PubMed Web of Science ®Google Scholar
• Deng X, Xiong W, Jiang X, et al. LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1. Cell Death Dis. 2020;11(11):945. doi:10.1038/s41419-020-03147-9
   PubMed Web of Science ®Google Scholar
• Pan J, Fang S, Tian H, et al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. Mol Cancer. 2020;19(1):9. doi:10.1186/s12943-020-1133-9
   PubMed Web of Science ®Google Scholar
• Kuo CL, Ponneri Babuharisankar A, Lin YC, et al. Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? J Biomed Sci. 2022;29(1):74. doi:10.1186/s12929-022-00859-2
   Web of Science ®Google Scholar
• Wang X, Xu D, Chen B, et al. Delicaflavone represses lung cancer growth by activating antitumor immune response through N6-methyladenosine transferases and oxidative stress. Oxid Med Cell Longev. 2022;2022:8619275. doi:10.1155/2022/8619275
   Web of Science ®Google Scholar
• Bhattacharyya S, Saha J. Tumour, oxidative stress and host T cell response: cementing the Dominance. Scand J Immunol. 2015;82(6):477–488. doi:10.1111/sji.12350
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu J, Fang Y, et al. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma. Front Immunol. 2022;13:950001. doi:10.3389/fimmu.2022.950001
   PubMed Web of Science ®Google Scholar
• Wang H, Tian RF, Liang X, et al. A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. Front Oncol. 2023;12:1015042. PMID: 36713541; PMCID: PMC9880292. doi:10.3389/fonc.2022.1015042
   Google Scholar
• Liu X, Zhang X, Liu C, Mu W, Peng J, Song K. Immune and inflammation: related factor alterations as biomarkers for predicting prognosis and responsiveness to PD-1 monoclonal antibodies in cervical cancer. Discov Oncol. 2022;13(1):96. doi:10.1007/s12672-022-00560-8
   Google Scholar
• Zhang D, Lu W, Zhuo Z, Mei H, Wu X, Cui Y. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration. Discov Oncol. 2022;13(1):78. doi:10.1007/s12672-022-00506-0
   Google Scholar
• Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807–821. doi:10.1038/s41423-020-0488-6
   PubMed Web of Science ®Google Scholar
• Zhou F, Qiao M, Zhou C. The cutting-edge progress of immune-checkpoint blockade in lung cancer. Cell Mol Immunol. 2021;18(2):279–293. doi:10.1038/s41423-020-00577-5
   PubMed Web of Science ®Google Scholar
• Rebuzzi SE, Leonetti A, Tiseo M, Facchinetti F. Advances in the prediction of long-term effectiveness of immune checkpoint blockers for non-small-cell lung cancer. Immunotherapy. 2019;11(12):993–1003. doi:10.2217/imt-2019-0107
   PubMed Web of Science ®Google Scholar
• Lahiri A, Maji A, Potdar PD, et al. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22(1):40. doi:10.1186/s12943-023-01740-y
   PubMed Web of Science ®Google Scholar